Keyphrases
Well-being
100%
Health Outcomes
100%
Sustainable Health
100%
Vascular Remodeling
100%
Empagliflozin
100%
Cardiovascular Disease
60%
Type 1 Diabetes Mellitus (T1DM)
40%
Antidiabetic Agents
40%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
40%
Risk Reduction
20%
Patients with Diabetes Mellitus
20%
Reactive Oxygen Species
20%
Endothelial Cells
20%
Inflammatory Response
20%
Diabetes Mellitus Patients
20%
Without Diabetes
20%
Non-communicable Diseases
20%
Google Scholar
20%
PubMed
20%
Vascular Disease
20%
Most Common Cause
20%
Sustainable Development Goal 3
20%
Nitric Oxide
20%
Adverse Outcomes
20%
Endothelium
20%
Causes of Mortality
20%
Good Health
20%
Structural Integrity
20%
Smooth muscle Cells
20%
Endothelial Glycocalyx
20%
Vascular Smooth muscle Cells
20%
Sustainable Development Indicators
20%
Cardiovascular Remodeling
20%
Cell Subsets
20%
Vascular Cells
20%
Endothelium-dependent Vasodilation
20%
Glycemic Efficacy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Vascular Remodeling
100%
Empagliflozin
100%
Diabetes Mellitus
80%
Cardiovascular Disease
60%
Antidiabetic Agent
40%
Sodium Glucose Cotransporter 2 Inhibitor
40%
Inflammation
20%
Reactive Oxygen Metabolite
20%
Bioavailability
20%
Vascular Disease
20%
Nitric Oxide
20%
Non Communicable Disease
20%
Adverse Outcome
20%